General Disclosure

General Disclosure of Financial Relationships Between FPA Physicians and Industry

Mount Sinai takes pride in the excellence and expertise of our physicians, and we make every effort to ensure that our physicians’ clinical decisions are made in the best interests of each patient. Often, as leaders in their respective fields, our physicians are highly qualified to collaborate with commercial companies in the development of new and innovative therapies to improve the treatment options for patients. Commercial companies also often support the education and research missions of Mount Sinai by making donations to these programs.

Mount Sinai believes that collaborative relationships with industry are vital to promoting innovations in patient care and treatment, inventing and testing new technology and advancing the continued education of our physicians in these new technologies. At the same time, however, Mount Sinai recognizes that these relationships must be carefully scrutinized to ensure that they do not bias or appear to influence the medical decisions of the institution or its physicians, and we have a vigorous program in place to review and manage such relationships.

It is important to Mount Sinai that you are aware of the potential relationships with industry and that you have the opportunity to ask any questions about such relationships. If you have such questions, we encourage you to discuss them with your physician.

Dr. Adams is a consultant to Edwards Lifesciences and receives compensation from the company for these services. As the co-inventor of the Carpentier-McCarthy-Adams IMR ETlogix Annuloplasty Ring and the Carpentier-Edwards Physio II Annuloplasty Ring, both Dr. Adams and Mount Sinai School of Medicine receive royalties from Edwards Lifesciences in connection with the sale of these products, but do not receive any royalties when he implants the devices in his patients at Mount Sinai.